FDA-cleared profile

Myomics

Phantomics Inc.

Authorized purpose: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.

Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Product overview

Start with the essentials

Authorized purpose: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.

Overview status: Source-reviewed overview

Clinical takeaway

Clinical role: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.

Evidence takeaway

Evidence from the reviewed source record: Exact FDA technical validation is available. Stored cardiac-MR publications require full version review before application to K241922; one unrelated myosin paper is excluded.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Qualified medical professionals experienced in examining and evaluating cardiovascular MR images
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Care setting and population
Hospital or private-practice cardiovascular MR analysis; manual workflows have no stated population restriction, while semi-automated ML workflows are adult-only.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Measurement, segmentation and quantification
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Required input
DICOM cardiovascular MR images acquired at 3.0 T; AI modules cover native/post-contrast T1 maps, T2 maps, CINE, LGE PSIR, CINE RV and LGE magnitude.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Output and human action
Semi-automatic endocardial/epicardial and myocardium segmentation across supported sequences, heart/adjacent-vessel measurements, image display, manual contouring and reports.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
Use only cardiac MR images from 3.0 T scanners. Semi-automated ML is intended for adults. Qualified cardiovascular-MR professionals must use results within comprehensive diagnostic assessment.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K241922
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
MRI
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-02-28
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
DICOM-standard cardiovascular MR import, display and export, worklist functions, contour tools and reporting.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Local PACS, EHR, HL7/FHIR and interface-version compatibility are not established.

Deployment and data flow
Stand-alone software application with a graphical interface, described for integration into hospital or private-practice environments.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

The summary does not establish current hosting architecture, compute sizing, region or latency.

Security and privacy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

Current data flow, access controls, retention, hosting and dated scoped security evidence remain unestablished.

Training and support
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

The FDA specifies experienced cardiovascular-MR users, but vendor onboarding, competency and support commitments are not established.

Monitoring and change control
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

Editorial acceptance question: assess each supported MR sequence, manual corrections and failed segmentations locally; no vendor monitoring capability is verified.

Vendor product-family context

Phantomics identifies Myomics as its cardiac MRI analysis solution and describes use in domestic and international hospitals; official manufacturer contact is available for configuration requests.

product family · checked 2026-09-05

Official Korean manufacturer page reviewed. Its family deployment narrative does not specify the K241922 release or establish current interfaces, security or clinical performance.

DICOM analysis workflow

Stand-alone GUI supports cardiovascular MR import/display/export, manual contours and reporting.

exact submission · checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Exact FDA technical validation is available. Stored cardiac-MR publications require full version review before application to K241922; one unrelated myosin paper is excluded.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

Reviewed exact-submission evidence reports segmentation overlap, not a disease-detection sensitivity.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

A disease-detection specificity for this release was not established in the reviewed sources.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K241922 Myomics bench and AI-module validation

  • DesignManufacturer bench comparison with Myomics Q/cvi42 Auto and held-out testing of seven segmentation modules
  • Population728 module-level anonymized test cases across MR vendors; module denominators 92, 91, 109, 90, 77, 192 and 77
  • Scopeexact submission
  • Tested versionMyomics configuration submitted in K241922; numerical release unspecified
  • Samplen=728
  • IndependenceSponsor or vendor study

K241922

Sample size is the summed module-case count, not confirmed unique patients. All modules reportedly exceeded mean Dice 0.7; detailed estimates, confidence intervals and reference-annotation methods were not established.

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

No exact license amount, unit, term or implementation/support costs were established from the reviewed FDA and manufacturer material.

Reimbursement and coding
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-09-05

Applicable CMS policy content has not been reviewed. Underlying cardiac MRI billing is not assigned to Myomics.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
21Fields reviewed
11Source classes checked
3Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

All three stored titles/dates screened. PMID 33053464 concerns myosin VI and is unrelated. PMIDs 36447413 and 39841643 are relevant cardiac-MR leads, but metadata alone does not establish K241922 version linkage; neither is promoted. Live PMID 36447413 retrieval returned HTTP 429. No stored trials. The current discovery snapshot contains 3 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, literature index, trial registry, vendor product page, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. FDA 510(k) K241922: Myomics

    U.S. Food and Drug Administration - Accessed 2026-09-05

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Myomics model card (K241922)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Phantomics About Us: Myomics cardiac MRI product-family context

    Phantomics - Accessed 2026-09-05

    Scope: productFamily, currentCommercialContext

Research history

  1. K241922 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K223523

Sonic DL

GE Medical Systems,LLC (GE Healthcare)

Sonic DL is deep-learning MRI reconstruction for highly undersampled or accelerated cardiac acquisitions on compatible GE 1.5T and 3.0T MRI systems for pediatric and adult...

Modality
MRI
Anatomy
Heart/Cardiovascular
Decision
2023-05-30
FDA-cleared K183274

RTHawk, HeartVista Cardiac Package

HeartVista, Inc.

Accessory acquisition, reconstruction, and display of cardiovascular MR images on compatible 1.5T and 3T whole-body MRI systems for trained-physician interpretation.

Modality
MRI
Anatomy
Heart/Cardiovascular
Decision
2019-10-18